Prot #INS-416: ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nont

Project: Research project

Project Details

StatusActive
Effective start/end date10/25/2110/25/24

Funding

  • PPD Development (Prot #INS-416)
  • Insmed Incorporated (Prot #INS-416)